Aug 4 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 140 mln 124 mln 800 mln
(+12.7 pct) (+5.1 pct) (+11.5 pct)
Operating loss 50 mln loss 42 mln loss 180 mln
Recurring loss 60 mln loss 41 mln loss 180 mln
Net loss 62 mln 20 mln loss 190 mln
EPS loss 8.65 yen 3.18 yen loss 28.14 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))